Thursday, October 24, 2019

Alembic Pharma gets USFDA nod for Desonide Ointment

Desonide Ointment, 0.05 per cent, is a low potency corticosteroid
indicated for the relief of the inflammatory and pruritic
manifestations of corticosteroid responsive dermatoses.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-usfda-nod-for-desonide-ointment/articleshow/71736150.cms

No comments:

Post a Comment